{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:17:14Z","timestamp":1787977034975,"version":"build-2784847793"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Roma La Sapienza"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Light-based therapies, including low-level light therapy (LLLT), have recently emerged as promising non-invasive approaches for dry eye disease (DED). This study evaluates the impact of a consumer-grade home-based LED Beauty Mask on DED parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective observational cohort study included 20 postmenopausal women (20 eyes) diagnosed with moderate DED and MGD who underwent cosmetic treatment using the LED Beauty Mask Koled\u00ae. The device was used for 20-min sessions on alternate days over a 3-week period. Clinical evaluations were performed at baseline, 3\u00a0weeks (T1), and 2\u00a0weeks (T2) after the last treatment and included tear osmolarity, tear film break-up time (TBUT), Schirmer I test, corneal fluorescein staining, and the Ocular Surface Disease Index (OSDI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Tear osmolarity demonstrated a significant improvement over time (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u00a00.001), with the most pronounced change observed at T1. Tear film stability, assessed by TBUT, also improved significantly (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.001). Subjective symptoms measured by OSDI showed a significant and sustained reduction (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u00a00.001). No significant changes were observed in Schirmer I test values (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.29). Corneal fluorescein staining present at baseline resolved by the final follow-up. Four eyes (20%) exhibited osmolarity values below the measurable range after treatment. No discomfort or adverse events were reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study suggests that a cosmetic LED mask may provide symptomatic and functional improvement in DED when repurposed for ocular use. Although preliminary and limited by sample size, these findings support further investigation through controlled clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10792-026-04219-z","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:25:17Z","timestamp":1787973917000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Home-based low-level light therapy using a commercial LED mask for dry eye disease"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4725-6778","authenticated-orcid":false,"given":"Luca","family":"Scuderi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6214-6270","authenticated-orcid":false,"given":"Serena","family":"Fragiotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6600-0917","authenticated-orcid":false,"given":"Chiara","family":"Ciancimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0744-0722","authenticated-orcid":false,"given":"Gianluca","family":"Scuderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"key":"4219_CR1","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.ajo.2013.12.023","volume":"157","author":"AJ Paulsen","year":"2014","unstructured":"Paulsen AJ, Cruickshanks KJ, Fischer ME, Huang GH, Klein BE, Klein R, Dalton DS (2014) Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol 157:799\u2013806. https:\/\/doi.org\/10.1016\/j.ajo.2013.12.023","journal-title":"Am J Ophthalmol"},{"key":"4219_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, Liu Z, Nelson JD, Nichols JJ, Tsubota K, Stapleton F (2017) TFOS DEWS II definition and classification report. Ocul Surf 15:276\u2013283. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.008","journal-title":"Ocul Surf"},{"key":"4219_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-026-01354-9","author":"B Gurnani","year":"2026","unstructured":"Gurnani B, Kaur K (2026) Redefining dry eye disease management: emerging pharmacologic and device-based therapies in the era of precision care: a narrative review. Ophthalmol Ther. https:\/\/doi.org\/10.1007\/s40123-026-01354-9","journal-title":"Ophthalmol Ther"},{"key":"4219_CR4","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1111\/opo.13371","volume":"44","author":"A Antwi","year":"2024","unstructured":"Antwi A, Schill AW, Redfern R, Ritchey ER (2024) Effect of low-level light therapy in individuals with dry eye disease. Ophthalmic Physiol Opt 44:1464\u20131471. https:\/\/doi.org\/10.1111\/opo.13371","journal-title":"Ophthalmic Physiol Opt"},{"key":"4219_CR5","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2147\/opth.S139894","volume":"11","author":"SJ Dell","year":"2017","unstructured":"Dell SJ (2017) Intense pulsed light for evaporative dry eye disease. Clin Ophthalmol 11:1167\u20131173. https:\/\/doi.org\/10.2147\/opth.S139894","journal-title":"Clin Ophthalmol"},{"key":"4219_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/icu.0000000000001154","volume":"36","author":"NRX Tan","year":"2025","unstructured":"Tan NRX, Chan KE, Lim BXH, Giannaccare G, Najjar RP, Lim CHL (2025) Photobiomodulation: evidence and applications in ophthalmology. Curr Opin Ophthalmol 36:345\u2013381. https:\/\/doi.org\/10.1097\/icu.0000000000001154","journal-title":"Curr Opin Ophthalmol"},{"key":"4219_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/ico.0000000000002997","volume":"42","author":"G Giannaccare","year":"2023","unstructured":"Giannaccare G, Pellegrini M, Carnovale Scalzo G, Borselli M, Ceravolo D, Scorcia V (2023) Low-level light therapy versus intense pulsed light for the treatment of meibomian gland dysfunction: preliminary results from a prospective randomized comparative study. Cornea 42:141\u2013144. https:\/\/doi.org\/10.1097\/ico.0000000000002997","journal-title":"Cornea"},{"key":"4219_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s40123-022-00619-3","volume":"12","author":"G Giannaccare","year":"2023","unstructured":"Giannaccare G, Vaccaro S, Pellegrini M, Borselli M, Carnovale Scalzo G, Taloni A, Pietropaolo R, Odadi AS, Carnevali A (2023) Serial sessions of a novel low-level light therapy device for home treatment of dry eye disease. Ophthalmol Ther 12:459\u2013468. https:\/\/doi.org\/10.1007\/s40123-022-00619-3","journal-title":"Ophthalmol Ther"},{"key":"4219_CR9","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1136\/bjo-2023-323920","volume":"108","author":"G Giannaccare","year":"2024","unstructured":"Giannaccare G, Rossi C, Borselli M, Carnovale Scalzo G, Scalia G, Pietropaolo R, Fratto B, Pellegrini M, Yu AC, Scorcia V (2024) Outcomes of low-level light therapy before and after cataract surgery for the prophylaxis of postoperative dry eye: a prospective randomised double-masked controlled clinical trial. Br J Ophthalmol 108:1172\u20131176. https:\/\/doi.org\/10.1136\/bjo-2023-323920","journal-title":"Br J Ophthalmol"},{"key":"4219_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/11206721221127206","author":"A Meduri","year":"2022","unstructured":"Meduri A, Oliverio GW, Tedesco G, Aragona P (2022) Combined intense pulsed light and low-level light therapy for the treatment of refractory meibomian gland dysfunction. Eur J Ophthalmol. https:\/\/doi.org\/10.1177\/11206721221127206","journal-title":"Eur J Ophthalmol"},{"key":"4219_CR11","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.2147\/opth.S521989","volume":"19","author":"S Farrant","year":"2025","unstructured":"Farrant S, Giannaccare G, Lim CHL, Coco G (2025) Intense pulsed light combined with low level blue and red light therapy for Demodex-associated blepharitis. Clin Ophthalmol 19:2575\u20132585. https:\/\/doi.org\/10.2147\/opth.S521989","journal-title":"Clin Ophthalmol"},{"key":"4219_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","volume":"15","author":"JS Wolffsohn","year":"2017","unstructured":"Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, Gupta PK, Karpecki P, Lazreg S, Pult H, Sullivan BD, Tomlinson A, Tong L, Villani E, Yoon KC, Jones L, Craig JP (2017) TFOS DEWS II diagnostic methodology report. Ocul Surf 15:539\u2013574. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.001","journal-title":"Ocul Surf"},{"key":"4219_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40123-025-01261-5","volume":"15","author":"R Fasciani","year":"2026","unstructured":"Fasciani R, Troisi S, Troisi M, Odorici S, Versura P (2026) A narrative review on the diagnosis of dry eye disease: insights from the Italian dry eye consensus (IDEC) group. Ophthalmol Ther 15:47\u201361. https:\/\/doi.org\/10.1007\/s40123-025-01261-5","journal-title":"Ophthalmol Ther"},{"key":"4219_CR14","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.4103\/IJO.IJO_2622_22","volume":"71","author":"S Singh","year":"2023","unstructured":"Singh S, Donthineni PR, Srivastav S, Jacobi C, Basu S, Paulsen F (2023) Lacrimal and meibomian gland evaluation in dry eye disease: a mini-review. Indian J Ophthalmol 71:1090\u20131098. https:\/\/doi.org\/10.4103\/IJO.IJO_2622_22","journal-title":"Indian J Ophthalmol"},{"key":"4219_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.clae.2016.06.006","volume":"39","author":"DH Szczesna-Iskander","year":"2016","unstructured":"Szczesna-Iskander DH (2016) Measurement variability of the TearLab osmolarity system. Cont Lens Anterior Eye 39:353\u2013358. https:\/\/doi.org\/10.1016\/j.clae.2016.06.006","journal-title":"Cont Lens Anterior Eye"},{"key":"4219_CR16","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.1038\/s41598-020-62583-x","volume":"10","author":"B Tashbayev","year":"2020","unstructured":"Tashbayev B, Utheim TP, Utheim \u00d8A, R\u00e6der S, Jensen JL, Yazdani M, Lagali N, Vitelli V, Dartt DA, Chen X (2020) Utility of tear osmolarity measurement in diagnosis of dry eye disease. Sci Rep 10:5542. https:\/\/doi.org\/10.1038\/s41598-020-62583-x","journal-title":"Sci Rep"},{"issue":"5","key":"4219_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"R Schiffman","year":"2000","unstructured":"Schiffman R, Christianson M, Jacobsen G, Hirsch J, Reis B (2000) Reliability and validity of the ocular surface disease index. Arch Ophthalmol 118(5):615\u2013621. https:\/\/doi.org\/10.1001\/archopht.118.5.615","journal-title":"Arch Ophthalmol"},{"key":"4219_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/life13091941","author":"R Martin","year":"2023","unstructured":"Martin R, Group ER (2023) Comparison of the ocular surface disease index and the symptom assessment in dry eye questionnaires for dry eye symptom assessment. Life (Basel). https:\/\/doi.org\/10.3390\/life13091941","journal-title":"Life (Basel)"},{"issue":"10","key":"4219_CR19","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.18240\/ijo.2021.10.18","volume":"14","author":"M Bakkar","year":"2021","unstructured":"Bakkar M, El-Sharif A, Qadire MA (2021) Validation of the Arabic version of the Ocular Surface Disease Index questionnaire. Int J Ophthalmol 14(10):1595\u20131601. https:\/\/doi.org\/10.18240\/ijo.2021.10.18","journal-title":"Int J Ophthalmol"},{"key":"4219_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-033940","author":"A Midorikawa-Inomata","year":"2019","unstructured":"Midorikawa-Inomata A, Inomata T, Nojiri S, Nakamura M, Iwagami M, Fujimoto K, Okumura Y, Iwata N, Eguchi A, Hasegawa H, Kinouchi H, Murakami A, Kobayashi H (2019) Reliability and validity of the Japanese version of the ocular surface disease index for dry eye disease. BMJ Open. https:\/\/doi.org\/10.1136\/bmjopen-2019-033940","journal-title":"BMJ Open"},{"key":"4219_CR21","doi-asserted-by":"publisher","DOI":"10.1109\/JSTQE.2016.2561201","author":"LF de Freitas","year":"2016","unstructured":"de Freitas LF, Hamblin MR (2016) Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE J Sel Top Quantum Electron. https:\/\/doi.org\/10.1109\/JSTQE.2016.2561201","journal-title":"IEEE J Sel Top Quantum Electron"},{"key":"4219_CR22","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1038\/s41598-022-07427-6","volume":"12","author":"Y Park","year":"2022","unstructured":"Park Y, Kim H, Kim S, Cho KJ (2022) Effect of low-level light therapy in patients with dry eye: a prospective, randomized, observer-masked trial. Sci Rep 12:3575. https:\/\/doi.org\/10.1038\/s41598-022-07427-6","journal-title":"Sci Rep"},{"key":"4219_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12886-022-02538-0","volume":"22","author":"L Vigo","year":"2022","unstructured":"Vigo L, Pellegrini M, Carones F, Scorcia V, Giannaccare G (2022) Outcomes of serial sessions of activa mask combined with intense pulsed light therapy in patients with meibomian gland dysfunction. BMC Ophthalmol 22:313. https:\/\/doi.org\/10.1186\/s12886-022-02538-0","journal-title":"BMC Ophthalmol"},{"key":"4219_CR24","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.2147\/OPTH.S95242","volume":"9","author":"R Potvin","year":"2015","unstructured":"Potvin R, Makari S, Rapuano CJ (2015) Tear film osmolarity and dry eye disease: a review of the literature. Clin Ophthalmol 9:2039\u20132047. https:\/\/doi.org\/10.2147\/OPTH.S95242","journal-title":"Clin Ophthalmol"},{"key":"4219_CR25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jcjo.2012.08.019","volume":"47","author":"G Scuderi","year":"2012","unstructured":"Scuderi G, Contestabile MT, Gagliano C, Iacovello D, Scuderi L, Avitabile T (2012) Effects of phytoestrogen supplementation in postmenopausal women with dry eye syndrome: a randomized clinical trial. Can J Ophthalmol 47:489\u2013492. https:\/\/doi.org\/10.1016\/j.jcjo.2012.08.019","journal-title":"Can J Ophthalmol"},{"key":"4219_CR26","doi-asserted-by":"publisher","first-page":"e2411651","DOI":"10.1002\/adma.202411651","volume":"36","author":"MS Kim","year":"2024","unstructured":"Kim MS, An J, Lee JH, Lee SH, Min S, Kim YB, Song M, Park SH, Nam KY, Park HJ, Kim KS, Oh SH, Hahn D, Moon J, Park JW, Park JS, Kim TS, Kim BJ, Lee KJ (2024) Clinical validation of face-fit surface-lighting micro light-emitting diode mask for skin anti-aging treatment. Adv Mater 36:e2411651. https:\/\/doi.org\/10.1002\/adma.202411651","journal-title":"Adv Mater"},{"key":"4219_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jphotobiol.2007.04.008","volume":"88","author":"SY Lee","year":"2007","unstructured":"Lee SY, Park KH, Choi JW, Kwon JK, Lee DR, Shin MS, Lee JS, You CE, Park MY (2007) A prospective, randomized, placebo-controlled, double-blinded, and split-face clinical study on LED phototherapy for skin rejuvenation: clinical, profilometric, histologic, ultrastructural, and biochemical evaluations and comparison of three different treatment settings. J Photochem Photobiol B 88:51\u201367. https:\/\/doi.org\/10.1016\/j.jphotobiol.2007.04.008","journal-title":"J Photochem Photobiol B"},{"key":"4219_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/icl.0000000000000958","volume":"49","author":"A Ballesteros-S\u00e1nchez","year":"2023","unstructured":"Ballesteros-S\u00e1nchez A, Gargallo-Mart\u00ednez B, S\u00e1nchez-Gonz\u00e1lez MC, S\u00e1nchez-Gonz\u00e1lez JM (2023) Intense pulse light combined with low-level light therapy in dry eye disease: a systematic review. Eye Contact Lens 49:8\u201313. https:\/\/doi.org\/10.1097\/icl.0000000000000958","journal-title":"Eye Contact Lens"},{"key":"4219_CR29","doi-asserted-by":"publisher","first-page":"Cd013559","DOI":"10.1002\/14651858.Cd013559","volume":"3","author":"S Cote","year":"2020","unstructured":"Cote S, Zhang AC, Ahmadzai V, Maleken A, Li C, Oppedisano J, Nair K, Busija L, Downie LE (2020) Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction. Cochrane Database Syst Rev 3:Cd013559. https:\/\/doi.org\/10.1002\/14651858.Cd013559","journal-title":"Cochrane Database Syst Rev"},{"key":"4219_CR30","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.4103\/ijo.Ijo_2834_22","volume":"71","author":"S D\u2019Souza","year":"2023","unstructured":"D\u2019Souza S, James E, Koul A, Modak D, Kundu G, Shetty R (2023) A randomized controlled study evaluating outcomes of intense pulsed light and low-level light therapy for treating meibomian gland dysfunction and evaporative dry eye. Indian J Ophthalmol 71:1608\u20131612. https:\/\/doi.org\/10.4103\/ijo.Ijo_2834_22","journal-title":"Indian J Ophthalmol"},{"key":"4219_CR31","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1097\/ico.0000000000002954","volume":"41","author":"S D\u2019Souza","year":"2022","unstructured":"D\u2019Souza S, Padmanabhan Nair A, Iyappan G, Dickman MM, Thakur P, Mullick R, Kundu G, Sethu S, Ghosh A, Shetty R (2022) Clinical and molecular outcomes after combined intense pulsed light therapy with low-level light therapy in recalcitrant evaporative dry eye disease with meibomian gland dysfunction. Cornea 41:1080\u20131087. https:\/\/doi.org\/10.1097\/ico.0000000000002954","journal-title":"Cornea"},{"key":"4219_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2023246","author":"M Di Marino","year":"2021","unstructured":"Di Marino M, Conigliaro P, Aiello F, Valeri C, Giannini C, Mancino R, Modica S, Nucci C, Perricone R, Cesareo M (2021) Combined low-level light therapy and intense pulsed light therapy for the treatment of dry eye in patients with Sj\u00f6gren\u2019s syndrome. J Ophthalmol. https:\/\/doi.org\/10.1155\/2021\/2023246","journal-title":"J Ophthalmol"},{"key":"4219_CR33","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jfo.2022.03.015","volume":"45","author":"M El Shami","year":"2022","unstructured":"El Shami M, Maroun A, Hoyek S, Antoun J (2022) Optimized combined low level light therapy and intense pulsed light therapy for the treatment of dry eye syndrome caused by Meibomian glands dysfunction. J Fr Ophtalmol 45:1126\u20131136. https:\/\/doi.org\/10.1016\/j.jfo.2022.03.015","journal-title":"J Fr Ophtalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04219-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-026-04219-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04219-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:25:19Z","timestamp":1787973919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-026-04219-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4219"],"URL":"https:\/\/doi.org\/10.1007\/s10792-026-04219-z","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]},"assertion":[{"value":"3 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no disclosed any conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Azienda Ospedaliera-Universitaria Sant\u2019Andrea.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work the author(s) used ChatGPT (OpenAI, GPT-5.3) in order to edit the figure. After using this tool\/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the published article.","order":4,"name":"Ethics","label":"Declaration of generative AI in scientific writing","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"356"}}